TSXV: CTH       Cynapsus Therapeutics In
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):0
Average Price Target:-


No recent Headlines for this stock.

Business Background

Cynapsus Therapeutics Inc. is a specialty pharmaceutical company developing non-injectable delivery of apomorphine to be used as a rescue therapy for off motor symptoms of Parkinson's disease. The Company's drug candidate, APL-130277, is a fast-acting reformulation of apomorphine, which is approved in an injection formulation to rescue patients from off episodes. APL-130277 is a bilayer film that incorporates a neutralizing agent. The Company is focused on clinical development and maximizing the commercialization potential of APL-130277, primarily through a semi-virtual outsourcing business model integrating a team of formulation developers, active pharmaceutical ingredient (API) suppliers, regulatory and intellectual property experts, neuroscientists and central nervous system researchers.

  Be the first to like this.


668  942  1279  1767 

Top 10 Active Counters
 ECA 4.89-0.30 
 APHA 6.97-0.61 
 META 0.20-0.07 
 BTE 1.52-0.10 
 ACB 2.60-0.13 
 HOU 5.15-0.27 
 N 0.52-0.05 
 BU 1.95+0.56 
 ROS 0.145+0.015 
 FCR 20.86+0.12 
Partners & Brokers